Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen J Hess

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Neurobiology of Disease|February 13, 2007
D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHDXueliang Fan, Ellen J Hess
Rare Diseases (Austin, Tex.)|May 4, 2016
A commentary on the utility of a new L-DOPA-responsive dystonia mouse modelSamuel J Rose, Ellen J Hess
Parkinsonism & Related Disorders|August 9, 2017
Evolving concepts in the pathogenesis of dystoniaH A Jinnah, Ellen J Hess
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 9, 2008
Experimental therapeutics for dystoniaH A Jinnah, Ellen J Hess
Pharmacology, Biochemistry, and Behavior|May 22, 2003
Norepinephrine regulates locomotor hyperactivity in the mouse mutant colobomaMichelle D Jones, Ellen J Hess
Neurobiology of Disease|July 15, 2006
The alpha(2C)-adrenergic receptor mediates hyperactivity of coloboma mice, a model of attention deficit hyperactivity disorderKristy J Bruno, Ellen J Hess
Neurobiology of Disease|October 26, 2005
Noradrenergic blockade prevents attacks in a model of episodic dysfunction caused by a channelopathyBrandy E Fureman, Ellen J Hess
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2013
Animal models for dystoniaBethany K Wilson, Ellen J Hess
Neurology|November 30, 2006
A new twist on the anatomy of dystonia: the basal ganglia and the cerebellum?H A Jinnah, Ellen J Hess
Neurobiology of Disease|October 21, 2009
D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHDXueliang Fan, Ming Xu, Ellen J Hess
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Neurobiology of Disease|February 13, 2007
D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHDXueliang Fan, Ellen J Hess
Rare Diseases (Austin, Tex.)|May 4, 2016
A commentary on the utility of a new L-DOPA-responsive dystonia mouse modelSamuel J Rose, Ellen J Hess
Parkinsonism & Related Disorders|August 9, 2017
Evolving concepts in the pathogenesis of dystoniaH A Jinnah, Ellen J Hess
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 9, 2008
Experimental therapeutics for dystoniaH A Jinnah, Ellen J Hess
Pharmacology, Biochemistry, and Behavior|May 22, 2003
Norepinephrine regulates locomotor hyperactivity in the mouse mutant colobomaMichelle D Jones, Ellen J Hess
Neurobiology of Disease|July 15, 2006
The alpha(2C)-adrenergic receptor mediates hyperactivity of coloboma mice, a model of attention deficit hyperactivity disorderKristy J Bruno, Ellen J Hess
Neurobiology of Disease|October 26, 2005
Noradrenergic blockade prevents attacks in a model of episodic dysfunction caused by a channelopathyBrandy E Fureman, Ellen J Hess
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2013
Animal models for dystoniaBethany K Wilson, Ellen J Hess
Neurology|November 30, 2006
A new twist on the anatomy of dystonia: the basal ganglia and the cerebellum?H A Jinnah, Ellen J Hess
Neurobiology of Disease|October 21, 2009
D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHDXueliang Fan, Ming Xu, Ellen J Hess
Pageof 8